Document is current
Any future updates will be listed below
-
Authors
Parsons, Janet A.
Wigle, Jannah
Zenlea, Ian
Ivers, Noah
Mukerji, Geetha
Landry, Alanna
Punthakee, Zubin
Clarson, Cheril L.
Shulman, Rayzel
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research - New Investigator Grants in Maternal, Reproductive, Child and Youth Health (155374, 155374, 155374, 155374, 155374, 155374, 155374, 155374, 155374)
Sickkids Research Institute
Hospital for Sick Children - Department of Pediatrics
- License Information
-
More Information
Article History
Received: 14 May 2024
Accepted: 9 October 2024
First Online: 23 October 2024
Declarations
:
: Ethics approval for this study was granted by the Clinical Trials Ontario (CTO) Streamlined Research Ethics Review System for four out of five study sites. CTO research sites participating in a multi-site research study undergo a single ethics review. The Trillium Health Partners Research Ethics Board also granted ethics approval. All participants provided written informed consent.
: Not applicable. All data in this paper have been de-identified.
: RS has received speaking and advisory board fees from Dexcom Canada. IZ reports receiving personal fees from Abbott Diabetes Care, Dexcom, Novo Nordisk Canada Inc., and the Ontario Association of Social Workers, and research funding support from the University of Toronto, Navigator Limited, Medical Psychiatry Alliance, Regional Municipality of Peel, Community Foundation of Mississauga, Canadian Institutes of Health Research. No other potential conflicts of interest relevant to this article were reported by the other authors.
